Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
Dan Shu, Meiying Shen, Kang Li, et al. Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy. Annals of Medicine. 2022;54(1):2581-2597. doi:10.1080/07853890.2022.2122550
Anna J. van der Zalm, João Barroso, Patience Browne, et al. A framework for establishing scientific confidence in new approach methodologies. Archives of Toxicology. 2022;96:2865-2879. doi:10.1007/s00204-022-03365-4
Merel Ritskes-Hoitinga, Pandora Pound. The role of systematic reviews in identifying the limitations of preclinical animal research, 2000-2022: part 2. Journal of the Royal Society of Medicine. 2022;115(6):231-235. doi:10.1177/01410768221100970
Merel Ritskes-Hoitinga, Pandora Pound. The role of systematic reviews in identifying the limitations of preclinical animal research, 2000-2022: part 1. Journal of the Royal Society of Medicine. 2022;115(5):186-192. doi:10.1177/01410768221093551
Ivan Rusyn, Courtney Sakolish, Yuki Kato, et al. Microphysiological Systems Evaluation: Experience of TEX-VAL Tissue Chip Testing Consortium. Toxicological Sciences: An Official Journal of the Society of Toxicology. 2022;188(2):143-152. doi:10.1093/toxsci/kfac061
Gui-Wei He, Lin Lin, Jeff DeMartino, et al. Optimized human intestinal organoid model reveals interleukin-22-dependency of paneth cell formation. Cell Stem Cell. 2022;29(9):1333-1345.e6. doi:10.1016/j.stem.2022.08.002
Claudia Günther, Beate Winner, Markus F. Neurath, Thaddeus S. Stappenbeck. Organoids in gastrointestinal diseases: from experimental models to clinical translation. Gut. 2022;71(9):1892-1908. doi:10.1136/gutjnl-2021-326560
Manuela Cassotta, Hugo Geerts, Lise Harbom, et al. The future of Parkinson’s disease research: A new paradigm of human-specific investigation is necessary… and possible. ALTEX. 2022;39(4):694-709. doi:10.14573/altex.2203161